Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$206K Buy
1,409
+16
+1% +$2.9K 0.09% 104
2026
Q1
$205K Buy
1,393
+29
+2% +$4.71K 0.1% 99
2025
Q4
$266K Buy
1,364
+113
+9% +$26.9K 0.07% 113
2025
Q3
$352K Buy
1,251
+63
+5% +$16K 0.09% 102
2025
Q2
$260K Buy
+1,188
New +$192K 0.08% 111
2021
Q3
Sell
-480
Closed -$37K 300
2021
Q2
$37K Buy
+480
New +$37.6K 0.01% 247
2021
Q1
Sell
-4,048
Closed -$262 584
2020
Q4
$262 Buy
4,048
+433
+12% +$25.8K ﹤0.01% 414
2020
Q3
$216K Sell
3,615
-4,461
-55% -$253K 0.06% 154
2020
Q2
$446K Buy
8,076
+42
+0.5% +$2.23K 0.06% 180
2020
Q1
$389K Hold
8,034
0.06% 164
2019
Q4
$389K Buy
+8,034
New +$442K 0.06% 189

Other funds holding ORCL

tru Independence's ORCL Position: Q2 2026 in Review

tru Independence increased its Oracle (ORCL) stake by 1.1% in Q2 2026, buying an estimated $2.9K and bringing the position to 1,409 shares worth $206K. The position accounts for 0.09% of the portfolio, ranked #104.

tru Independence first reported a position in ORCL in Q4 2019 and has held it in 11 quarters since. The position peaked at $446K in Q2 2020. 3,518 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • tru Independence held 1,409 shares of Oracle worth $206K as of Q2 2026.
  • tru Independence bought 16 Oracle shares in Q2 2026, an estimated $2.9K.
  • Oracle made up 0.09% of tru Independence's portfolio in Q2 2026, its #104 holding.
  • tru Independence first reported a position in Oracle in Q4 2019 and has held it in 11 quarters since.
  • tru Independence's Oracle position peaked at $446K in Q2 2020.
  • 3,518 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on tru Independence's 13F filing for Q2 2026, filed 10 Aug 2026.